Differences in serum selenoprotein P profile between C57BL/6 and BALB/c mice fed high-fat diet

C57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these strains also show different expression profiles of selenoprotein P, a diabetes-related hepatokine, after HFD feeding is unclear. We investigated t...

Full description

Saved in:
Bibliographic Details
Published inJournal of trace elements in medicine and biology Vol. 81; p. 127340
Main Authors Ando, Motozumi, Suzuki, Keiko, Kitamoto, Riko, Nakayama, Ayako, Watanabe, Norio, Kawahara, Masami
Format Journal Article
LanguageEnglish
Published Germany 01.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract C57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these strains also show different expression profiles of selenoprotein P, a diabetes-related hepatokine, after HFD feeding is unclear. We investigated the effects of HFD on body weight, glucose metabolism, and plasma selenoprotein P levels in C57BL/6 and BALB/c mice. Male C57BL/6 and BALB/c mice aged seven weeks were divided into normal diet (ND) and HFD groups. Fasting body weights and blood sugar levels were measured weekly. Blood specimens were collected after 16 h of fasting (in weeks 7, 9, and 11) and after 24 h of subsequent refeeding (in weeks 9 and 11) to analyse plasma selenoprotein P and insulin levels. The mean body weight of the HFD group was consistently higher than that of the ND group for both strains. However, a significant elevation in fasting plasma glucose levels from the early stage was observed only in the HFD group of C57BL/6 mice. In BALB/c mice, a difference in fasting glucose levels between the HFD and ND groups was observed after nine weeks. After seven, nine, and eleven weeks, the fasting plasma insulin levels were higher in the HFD group than in the ND group for both strains. During this period, plasma selenoprotein P levels in the HFD group were significantly higher than those in the ND group of C57BL/6 mice. However, BALB/c mice did not show a significant difference in plasma levels of selenoprotein P between the ND and HFD groups. After refeeding, the plasma insulin and selenoprotein P levels increased compared to those observed during fasting in the ND group for both strains. Elevation of insulin levels, but not of selenoprotein P levels, after refeeding was noticed in the HFD group for both strains. Plasma selenoprotein P level after refeeding was significantly lower than that during fasting in the HFD group of C57BL/6 mice. Unlike C57BL/6 mice, BALB/c mice did not show elevated fasting plasma selenoprotein P levels despite HFD feeding. Additionally, the pattern of selenoprotein P levels in the plasma after refeeding differed between C57BL/6 and BALB/c mice. These differences in selenoprotein P expression among strains may be related to different susceptibilities of individuals to diabetes.
AbstractList C57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these strains also show different expression profiles of selenoprotein P, a diabetes-related hepatokine, after HFD feeding is unclear. We investigated the effects of HFD on body weight, glucose metabolism, and plasma selenoprotein P levels in C57BL/6 and BALB/c mice.BACKGROUNDC57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these strains also show different expression profiles of selenoprotein P, a diabetes-related hepatokine, after HFD feeding is unclear. We investigated the effects of HFD on body weight, glucose metabolism, and plasma selenoprotein P levels in C57BL/6 and BALB/c mice.Male C57BL/6 and BALB/c mice aged seven weeks were divided into normal diet (ND) and HFD groups. Fasting body weights and blood sugar levels were measured weekly. Blood specimens were collected after 16 h of fasting (in weeks 7, 9, and 11) and after 24 h of subsequent refeeding (in weeks 9 and 11) to analyse plasma selenoprotein P and insulin levels.METHODSMale C57BL/6 and BALB/c mice aged seven weeks were divided into normal diet (ND) and HFD groups. Fasting body weights and blood sugar levels were measured weekly. Blood specimens were collected after 16 h of fasting (in weeks 7, 9, and 11) and after 24 h of subsequent refeeding (in weeks 9 and 11) to analyse plasma selenoprotein P and insulin levels.The mean body weight of the HFD group was consistently higher than that of the ND group for both strains. However, a significant elevation in fasting plasma glucose levels from the early stage was observed only in the HFD group of C57BL/6 mice. In BALB/c mice, a difference in fasting glucose levels between the HFD and ND groups was observed after nine weeks. After seven, nine, and eleven weeks, the fasting plasma insulin levels were higher in the HFD group than in the ND group for both strains. During this period, plasma selenoprotein P levels in the HFD group were significantly higher than those in the ND group of C57BL/6 mice. However, BALB/c mice did not show a significant difference in plasma levels of selenoprotein P between the ND and HFD groups. After refeeding, the plasma insulin and selenoprotein P levels increased compared to those observed during fasting in the ND group for both strains. Elevation of insulin levels, but not of selenoprotein P levels, after refeeding was noticed in the HFD group for both strains. Plasma selenoprotein P level after refeeding was significantly lower than that during fasting in the HFD group of C57BL/6 mice.RESULTSThe mean body weight of the HFD group was consistently higher than that of the ND group for both strains. However, a significant elevation in fasting plasma glucose levels from the early stage was observed only in the HFD group of C57BL/6 mice. In BALB/c mice, a difference in fasting glucose levels between the HFD and ND groups was observed after nine weeks. After seven, nine, and eleven weeks, the fasting plasma insulin levels were higher in the HFD group than in the ND group for both strains. During this period, plasma selenoprotein P levels in the HFD group were significantly higher than those in the ND group of C57BL/6 mice. However, BALB/c mice did not show a significant difference in plasma levels of selenoprotein P between the ND and HFD groups. After refeeding, the plasma insulin and selenoprotein P levels increased compared to those observed during fasting in the ND group for both strains. Elevation of insulin levels, but not of selenoprotein P levels, after refeeding was noticed in the HFD group for both strains. Plasma selenoprotein P level after refeeding was significantly lower than that during fasting in the HFD group of C57BL/6 mice.Unlike C57BL/6 mice, BALB/c mice did not show elevated fasting plasma selenoprotein P levels despite HFD feeding. Additionally, the pattern of selenoprotein P levels in the plasma after refeeding differed between C57BL/6 and BALB/c mice. These differences in selenoprotein P expression among strains may be related to different susceptibilities of individuals to diabetes.CONCLUSIONUnlike C57BL/6 mice, BALB/c mice did not show elevated fasting plasma selenoprotein P levels despite HFD feeding. Additionally, the pattern of selenoprotein P levels in the plasma after refeeding differed between C57BL/6 and BALB/c mice. These differences in selenoprotein P expression among strains may be related to different susceptibilities of individuals to diabetes.
C57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these strains also show different expression profiles of selenoprotein P, a diabetes-related hepatokine, after HFD feeding is unclear. We investigated the effects of HFD on body weight, glucose metabolism, and plasma selenoprotein P levels in C57BL/6 and BALB/c mice. Male C57BL/6 and BALB/c mice aged seven weeks were divided into normal diet (ND) and HFD groups. Fasting body weights and blood sugar levels were measured weekly. Blood specimens were collected after 16 h of fasting (in weeks 7, 9, and 11) and after 24 h of subsequent refeeding (in weeks 9 and 11) to analyse plasma selenoprotein P and insulin levels. The mean body weight of the HFD group was consistently higher than that of the ND group for both strains. However, a significant elevation in fasting plasma glucose levels from the early stage was observed only in the HFD group of C57BL/6 mice. In BALB/c mice, a difference in fasting glucose levels between the HFD and ND groups was observed after nine weeks. After seven, nine, and eleven weeks, the fasting plasma insulin levels were higher in the HFD group than in the ND group for both strains. During this period, plasma selenoprotein P levels in the HFD group were significantly higher than those in the ND group of C57BL/6 mice. However, BALB/c mice did not show a significant difference in plasma levels of selenoprotein P between the ND and HFD groups. After refeeding, the plasma insulin and selenoprotein P levels increased compared to those observed during fasting in the ND group for both strains. Elevation of insulin levels, but not of selenoprotein P levels, after refeeding was noticed in the HFD group for both strains. Plasma selenoprotein P level after refeeding was significantly lower than that during fasting in the HFD group of C57BL/6 mice. Unlike C57BL/6 mice, BALB/c mice did not show elevated fasting plasma selenoprotein P levels despite HFD feeding. Additionally, the pattern of selenoprotein P levels in the plasma after refeeding differed between C57BL/6 and BALB/c mice. These differences in selenoprotein P expression among strains may be related to different susceptibilities of individuals to diabetes.
ArticleNumber 127340
Author Watanabe, Norio
Suzuki, Keiko
Kawahara, Masami
Kitamoto, Riko
Nakayama, Ayako
Ando, Motozumi
Author_xml – sequence: 1
  givenname: Motozumi
  orcidid: 0000-0003-2473-0588
  surname: Ando
  fullname: Ando, Motozumi
– sequence: 2
  givenname: Keiko
  surname: Suzuki
  fullname: Suzuki, Keiko
– sequence: 3
  givenname: Riko
  surname: Kitamoto
  fullname: Kitamoto, Riko
– sequence: 4
  givenname: Ayako
  surname: Nakayama
  fullname: Nakayama, Ayako
– sequence: 5
  givenname: Norio
  surname: Watanabe
  fullname: Watanabe, Norio
– sequence: 6
  givenname: Masami
  surname: Kawahara
  fullname: Kawahara, Masami
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37984217$$D View this record in MEDLINE/PubMed
BookMark eNo9kMtOwzAQRS1URB_wBUjISzZJ_YrtLNvylCrBogtWWI4zponyKHEqxN-T0sJmZjQ6uro6UzRq2gYQuqYkpoTKeRmXPdRZzAjjMWWKC3KGJlQrHXGWsBGakFTISCr2NkbTEEpCqEo0u0BjrlItGFUT9H5XeA8dNA4CLhocoNvXw6ygaXdd28Pwe8XD5YsKcAb9F0CDV4larucS2ybHy8V6OXe4LhxgDzneFh_byNse5wX0l-jc2yrA1WnP0ObhfrN6itYvj8-rxTpynNE-SoVIc251JkD5hHOZJBJkQrjNOGXCpZ5Lr73PFJVZygW12lmaeJFZSlzKZ-j2GDsU_dxD6E1dBAdVZRto98EwnTKmqJZyQG9O6D6rITe7rqht923-lAwAPwKua0PowP8jlJiDeFOaX_HmIN4cxfMfm911MQ
Cites_doi 10.1016/j.redox.2022.102236
10.1074/jbc.M111.238311
10.1002/hep.22526
10.3758/BF03193146
10.1002/jcp.30121
10.1016/j.freeradbiomed.2013.07.016
10.1074/jbc.C100109200
10.1007/s00125-013-2846-8
10.1016/j.bbalip.2016.08.016
10.1074/jbc.M116.747006
10.1038/bmt.2012.244
10.1016/j.orcp.2016.07.004
10.1128/MCB.00293-12
10.1016/j.jhep.2020.11.030
10.1073/pnas.1213343109
10.1038/s41586-019-1797-8
10.3390/ijms21228838
10.1042/CS20110366
10.1037/0033-2909.112.1.155
10.1016/j.cmet.2010.09.015
ContentType Journal Article
Copyright Copyright © 2023 Elsevier GmbH. All rights reserved.
Copyright_xml – notice: Copyright © 2023 Elsevier GmbH. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jtemb.2023.127340
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1878-3252
ExternalDocumentID 37984217
10_1016_j_jtemb_2023_127340
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29L
4.4
457
4G.
53G
5GY
5VS
7-5
71M
7X7
88E
88I
8AF
8FE
8FH
8FI
8FJ
8P~
8R4
8R5
AAEDT
AAEDW
AAIKJ
AAKOC
AAKPP
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATTM
AAXKI
AAXUO
AAYWO
AAYXX
ABBQC
ABFNM
ABFRF
ABFYP
ABGSF
ABJNI
ABKYH
ABLST
ABMAC
ABMZM
ABRWV
ABUDA
ABUWG
ABWVN
ABXDB
ABZDS
ACDAQ
ACGFO
ACGFS
ACGOD
ACIEU
ACJTP
ACMHX
ACNNM
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADECG
ADEZE
ADKUU
ADMUD
ADNMO
ADSLC
ADUVX
ADVLN
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEXOQ
AFJKZ
AFKRA
AFPUW
AFTJW
AFXBA
AFXIZ
AFZHZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGRNS
AGUBO
AGWPP
AGYEJ
AHEUO
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJSZI
AKBMS
AKIFW
AKRWK
AKYEP
ALCLG
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BBNVY
BENPR
BES
BHPHI
BKOJK
BLECG
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DWQXO
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
FYUFA
G-Q
GBLVA
GNUQQ
HCIFZ
HMCUK
HVGLF
HX~
HZ~
IHE
J1W
KCYFY
KOM
LK8
M1P
M2P
M2Q
M41
M7P
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PZZ
Q2X
Q38
R2-
RIG
ROL
RPZ
S0X
SCB
SDF
SDG
SES
SEW
SNG
SNL
SPC
SPCBC
SSH
SSJ
SSK
SSP
SSU
SSZ
T5I
T5J
T5K
UKHRP
UNMZH
~G-
AACTN
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c321t-9449d3a8b4e7f5336556e6503ab3124c9f36f8ffb716b9341a8ca15f4ba10c93
ISSN 0946-672X
1878-3252
IngestDate Fri Jul 11 07:03:10 EDT 2025
Thu Apr 03 07:05:21 EDT 2025
Tue Jul 01 03:22:37 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Type 2 diabetes
Insulin resistance
Hyperglycaemia
Selenoprotein P
Hepatokine
High fat diet
Language English
License Copyright © 2023 Elsevier GmbH. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c321t-9449d3a8b4e7f5336556e6503ab3124c9f36f8ffb716b9341a8ca15f4ba10c93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2473-0588
PMID 37984217
PQID 2892271866
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2892271866
pubmed_primary_37984217
crossref_primary_10_1016_j_jtemb_2023_127340
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-00
2024-Jan
20240101
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-00
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Journal of trace elements in medicine and biology
PublicationTitleAlternate J Trace Elem Med Biol
PublicationYear 2024
References Kupriyanova (10.1016/j.jtemb.2023.127340_bib9) 2021; 74
Steinbrenner (10.1016/j.jtemb.2023.127340_bib1) 2013; 65
Faul (10.1016/j.jtemb.2023.127340_bib13) 2007; 39
Tajima-Shirasaki (10.1016/j.jtemb.2023.127340_bib18) 2017; 292
Chen (10.1016/j.jtemb.2023.127340_bib4) 2021; 236
Caviglia (10.1016/j.jtemb.2023.127340_bib6) 2020; 21
Speckmann (10.1016/j.jtemb.2023.127340_bib20) 2008; 48
Misu (10.1016/j.jtemb.2023.127340_bib7) 2010; 12
Seale (10.1016/j.jtemb.2023.127340_bib8) 2012; 32
Cohen (10.1016/j.jtemb.2023.127340_bib14) 1992; 112
Montgomery (10.1016/j.jtemb.2023.127340_bib16) 2016; 1861
Owen (10.1016/j.jtemb.2023.127340_bib17) 2012; 109
Roden (10.1016/j.jtemb.2023.127340_bib3) 2019; 576
Montgomery (10.1016/j.jtemb.2023.127340_bib11) 2013; 56
Maina (10.1016/j.jtemb.2023.127340_bib15) 2012; 122
Steinbrenner (10.1016/j.jtemb.2023.127340_bib10) 2022; 50
Motamed (10.1016/j.jtemb.2023.127340_bib19) 2011; 286
Chen (10.1016/j.jtemb.2023.127340_bib5) 2017; 11
Kanda (10.1016/j.jtemb.2023.127340_bib12) 2013; 48
Mahadev (10.1016/j.jtemb.2023.127340_bib2) 2001; 276
References_xml – volume: 50
  year: 2022
  ident: 10.1016/j.jtemb.2023.127340_bib10
  article-title: The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2022.102236
– volume: 286
  start-page: 18002
  year: 2011
  ident: 10.1016/j.jtemb.2023.127340_bib19
  article-title: Identification of luminal Loop 1 of Scap protein as the sterol sensor that maintains cholesterol homeostasis
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.238311
– volume: 48
  start-page: 1998
  year: 2008
  ident: 10.1016/j.jtemb.2023.127340_bib20
  article-title: Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors
  publication-title: Hepatology
  doi: 10.1002/hep.22526
– volume: 39
  start-page: 175
  year: 2007
  ident: 10.1016/j.jtemb.2023.127340_bib13
  article-title: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences
  publication-title: Behav. Res. Methods
  doi: 10.3758/BF03193146
– volume: 236
  start-page: 3800
  year: 2021
  ident: 10.1016/j.jtemb.2023.127340_bib4
  article-title: SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK/ACC pathway
  publication-title: J. Cell Physiol.
  doi: 10.1002/jcp.30121
– volume: 65
  start-page: 1538
  year: 2013
  ident: 10.1016/j.jtemb.2023.127340_bib1
  article-title: Interference of selenium and selenoproteins with the insulin-regulated carbohydrate and lipid metabolism
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2013.07.016
– volume: 276
  start-page: 21938
  year: 2001
  ident: 10.1016/j.jtemb.2023.127340_bib2
  article-title: Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.C100109200
– volume: 56
  start-page: 1129
  year: 2013
  ident: 10.1016/j.jtemb.2023.127340_bib11
  article-title: Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding
  publication-title: Diabetologia
  doi: 10.1007/s00125-013-2846-8
– volume: 1861
  start-page: 1828
  year: 2016
  ident: 10.1016/j.jtemb.2023.127340_bib16
  article-title: Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: a beneficial role for very long-chain sphingolipid species
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbalip.2016.08.016
– volume: 292
  start-page: 10791
  year: 2017
  ident: 10.1016/j.jtemb.2023.127340_bib18
  article-title: Eicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M116.747006
– volume: 48
  start-page: 452
  year: 2013
  ident: 10.1016/j.jtemb.2023.127340_bib12
  article-title: Investigation of the freely available easy-to-use software “EZR” for medical statistics
  publication-title: Bone Marrow Transpl.
  doi: 10.1038/bmt.2012.244
– volume: 11
  start-page: 227
  year: 2017
  ident: 10.1016/j.jtemb.2023.127340_bib5
  article-title: Selenoprotein P is elevated in individuals with obesity, but is not independently associated with insulin resistance
  publication-title: Obes. Res Clin. Pract.
  doi: 10.1016/j.orcp.2016.07.004
– volume: 32
  start-page: 4141
  year: 2012
  ident: 10.1016/j.jtemb.2023.127340_bib8
  article-title: Disruption of the selenocysteine lyase-mediated selenium recycling pathway leads to metabolic syndrome in mice
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.00293-12
– volume: 74
  start-page: 1028
  year: 2021
  ident: 10.1016/j.jtemb.2023.127340_bib9
  article-title: Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2020.11.030
– volume: 109
  start-page: 16184
  year: 2012
  ident: 10.1016/j.jtemb.2023.127340_bib17
  article-title: Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1213343109
– volume: 576
  start-page: 51
  year: 2019
  ident: 10.1016/j.jtemb.2023.127340_bib3
  article-title: The integrative biology of type 2 diabetes
  publication-title: Nature
  doi: 10.1038/s41586-019-1797-8
– volume: 21
  year: 2020
  ident: 10.1016/j.jtemb.2023.127340_bib6
  article-title: Interplay between oxidative stress and metabolic derangements in non-alcoholic fatty liver disease: the role of selenoprotein P
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21228838
– volume: 122
  start-page: 545
  year: 2012
  ident: 10.1016/j.jtemb.2023.127340_bib15
  article-title: Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice
  publication-title: Clin. Sci.
  doi: 10.1042/CS20110366
– volume: 112
  start-page: 155
  year: 1992
  ident: 10.1016/j.jtemb.2023.127340_bib14
  article-title: A power primer
  publication-title: Psychol. Bull.
  doi: 10.1037/0033-2909.112.1.155
– volume: 12
  start-page: 483
  year: 2010
  ident: 10.1016/j.jtemb.2023.127340_bib7
  article-title: A liver-derived secretory protein, selenoprotein P, causes insulin resistance
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2010.09.015
SSID ssj0017582
Score 2.3529487
Snippet C57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
StartPage 127340
SubjectTerms Animals
Blood Glucose - metabolism
Body Weight
Diabetes Mellitus
Diet, High-Fat - adverse effects
Insulins
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Selenoprotein P
Title Differences in serum selenoprotein P profile between C57BL/6 and BALB/c mice fed high-fat diet
URI https://www.ncbi.nlm.nih.gov/pubmed/37984217
https://www.proquest.com/docview/2892271866
Volume 81
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BeuGCgPIILy0S4mKcxt7165iUVoGmoQdXyglrvd6V0so2KvYh-fXMPhwnIkiFyyqZOLvRzJfRvHYGoY8BYZRSGbtEhjE4KAFx85DDQjwiC68Qhc7oXi7C2TX9tgyWfUxX3y5p8hHfHLxX8j9SBRrIVd2S_QfJbjcFArwG-cIKEob1XjL-YqebmKoqB85sS0eNT6pq3X8BaFeOncq9rcg6DaLpHM4Mdd5gOplP4Q131Fh6R4L5qRoYu5I1TrESe4H7Hdu1uWPwtDCl5_rsLkevN7WdnfoQQ6EDspd1U2_actUnojatmZp9IVa3dV8O0DAAUG3u_ff0Bbtla1aaQPCa2Q9sxMKnOxELo2RjVZLhm861I3GAZjWzGeZiVaunGvGMD2p9E4C4AXaIMh-pgfCj_un9HtuL79n59XyepWfL9CE68sG58AfoaPL1YrbYZp_Ah9JZ8u43dd2qdF3gH4fsWzR_cVO0uZI-QY-trPDEgOYpeiCqZ-h4UrGmLtf4E9aVv1pKx-jHDo7wqsIaR3gPR_gKWxxhiyOscXQSYhA4Vig64VhhCAOGcIchrDD0HKXnZ-npzLVzN1xOfK9xE0qTgrA4pyKS4A6EQRAKsOQJg3-wT3kiSShjKXPwtfMEzCAWc-YFkubMG_OEvECDqq7EK4TjImdg01LuRYyKIIijgiWc5uOkKDwq-RB97liX_TTdVbKu7PAm05zOFKczw-kh-tCxNwMtqFJbrBJ1-yvz48T3I9W8cYheGr5vNyRRElPwvF_f49tv0KMesW_RoLlrxTuwOpv8vQXJb7YKgRo
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differences+in+serum+selenoprotein+P+profile+between+C57BL%2F6+and+BALB%2Fc+mice+fed+high-fat+diet&rft.jtitle=Journal+of+trace+elements+in+medicine+and+biology&rft.au=Ando%2C+Motozumi&rft.au=Suzuki%2C+Keiko&rft.au=Kitamoto%2C+Riko&rft.au=Nakayama%2C+Ayako&rft.date=2024-01-01&rft.issn=1878-3252&rft.eissn=1878-3252&rft.volume=81&rft.spage=127340&rft_id=info:doi/10.1016%2Fj.jtemb.2023.127340&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0946-672X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0946-672X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0946-672X&client=summon